Annovis Bio, Inc.: Annovis Bio to Present at the H.C. Wainwright Global Life Sciences Conference
Berwyn, Pennsylvania (Newsfile Corp. - March 9, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer s disease (AD), Parkinson s disease (PD) and other neurodegenerative diseases, today announced that Maria Maccecchini, Ph.D., Founder and Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference. Annovis Bio s presentation will be available online beginning March 9, 2021 at 7:00 a.m. ET., and the presentation will be archived and available for replay for 90 days after the event.
The register and view the webcast, visit: https://journey.ct.events/view/f6675119-df47-4bf8-8553-6891b8fb3ee4
ID Global Corporation: IDGlobal Corp. Announces Corporate Update
WHEATON, IL / ACCESSWIRE / March 9, 2021 / IDGlobal Corp. (OTC PINK:IDGC) is pleased to announce a corporate update addressing status of Financials, Imminent acquisitions, and New management hires.
The company has retained counsel specializing in corporate structure to include the new OTC Markets requirements, retirement of existing restricted stock issuances, and the build-out of the Board of Directors.
The Board of Directors is in the final stages of acquiring majority ownership of a global management company, comprised of Fortune 500 executives, that manage every aspect of getting new technology products ready for retail, reaching the end user, the consumer, and building each retailers product categories incrementally.
German government resolved to approve a new supply chain law Lieferkettensgesetz that would impose unprecedented obligations on German companies to control labor and control practices – not only of their own operations, but within their supplier as well.
Miton Global Opportunities Plc - Net Asset Value(s) PR Newswire London, March 9 MITON GLOBAL OPPORTUNITIES PLC NET ASSET VALUE The estimated un-audited net asset